20. Acute and sub-chronic oral toxicity studies of “Tri 02” powder in experimental animals

Nguyen Thi Thai, Pham Thi Van Anh , Nguyen Thị Thu Ha, Do Linh Quyen, Nguyen Van Phuc, Dang Thi Thu Hien

Nội dung chính của bài viết

Tóm tắt

This study aims to assess the acute and sub-chronic oral toxicity of “Tri 02” powder in experimental animals. According to World Health Organization Guidance, acute toxicity study was conducted using Swiss mice. LD50 was determined by Litchfield-Wilcoxon method, and sub-chronic toxicity of “Tri 02” at two doses (2.4 g/kg b.w/day and 7.2 g/kg b.w/day) was assessed in Wistar rats for four uninterrupted weeks. Abnormal behavior, toxic symptoms, and death were observed for 7 consecutive days to assess the effects of acute toxicity. The general behavior of the rats was observed daily, and their body weight was recorded weekly. Hematological analysis and biochemical analysis were conducted before treatment, and at 2 and 4 weeks of treatment. Macroscopic examination and histopathological examination of several organs were conducted at the end of the treatment period. The results suggested that “Tri 02” at the highest dose used for mice (187.5 g/kg b.w) did not show acute toxicity and the LD50 was determined. In terms of the sub-chonic toxicity test, after oral administration of “Tri 02” powder, hematological parameters, hepato-renal functions and microscopic images of liver and kidney at both doses were similar to the control group. In conclusion, “Tri 02” powder did not produce the acute and subchronic oral toxicity in experimental animals.

Chi tiết bài viết

Tài liệu tham khảo

1. Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: From prejudice to evidence. Evid-Based Complement Altern Med ECAM. 2015; 2015: 316706. doi:10.1155/2015/316706.
2. Fischer I, Milton C, Wallace H. Toxicity testing is evolving!. Toxicol Res. 2020; 9(2): 67-80. doi:10.1093/toxres/tfaa011.
3. Luo M, Luo H, Hu P, Yang Y, Wu B, Zheng G. Evaluation of chemical components in Citri Reticulatae Pericarpium of different cultivars collected from different regions by GC–MS and HPLC. Food Sci Nutr. 2017; 6(2): 400-416. doi:10.1002/fsn3.569.
4. El-Saber Batiha G, Magdy Beshbishy A, El-Mleeh A, M. Abdel-Daim M, Prasad Devkota H. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules. 2020; 10(3): 352. doi:10.3390/biom10030352.
5. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. A Review of the Pharmacological Action of Astragalus Polysaccharide. Front Pharmacol. 2020; 11: 349. doi:10.3389/fphar.2020.00349
6. World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Published online 2007: 105.
7. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96(2): 99-113.
8. Chronic Toxicity Study - an overview. ScienceDirect Topics. Accessed August 21, 2022. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/chronic-toxicity-study.
9. Kim DG, Lee J, Kim W, et al. Assessment of general toxicity of the glycyrrhiza new variety extract in rats. Plants. 2021; 10: 1126. doi:10.3390/plants10061126.
10. Sayyad M, Tiang N, Kumari Y, et al. Acute toxicity profiling of the ethyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection studies. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2017; 25(2): 196-205. doi:10.1016/j.jsps.2016.05.002.
11. Children NRC (US) C on P in the D of I and. Methods for Toxicity Testing. National Academies Press (US); 1993.